PM Academy Webinar Series: Managing difficult conversations | What impact can PCNs have on the CV agenda?
These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.
|Event Name||PM Academy Webinar Series: Managing difficult conversations | What impact can PCNs have on the CV agenda?|
|Location||Virtual - Joining link will be sent 48 hours prior|
|Start Date||10:00am 15/09/2021|
|Finish Date||11:45am 15/09/2021|
|Booking Closes||No longer taking bookings|
A regular series of fortnightly webinars to support professional development and enhancement of patient care by the sharing of best practice.
Utilising PM Trainers from the successful Clinical Leadership in Pharmacy (CLIP) programme to deliver practical learning sessions of skills designed to aid personal and organisation development.
To complement skills acquisition there will be a second session in the webinar to exchange best practice which will be delivered by presenters whose satellite sessions have been significantly oversubscribed at Pharmacy Management Conferences.
It is anticipated the PM ACADEMY will be very popular so early registration for each webinar is recommended.
WEBINAR SESSION SYNOPSES AND SPEAKER DETAILS
Managing difficult conversations - PM Consultancy Trainer
Managing difficult conversations is a challenging situation for many, and often avoided by many - this session will help you identify what assertive behaviour is in comparison to the naturally seen styles of passive and aggressive behaviour. We will then look at how to use assertive communication and why it is critical to adapt your natural style accordingly. To help you to do this, you will be introduced to a simple feedback model, which will be demonstrated during the session.
What impact can PCNs have on the CV agenda? - Rachel Howatson, Senior Cardiovascular Disease Pharmacist, NHS Southwark CCG
With a focus on how PCN pharmacists may support the NHS long term plan, ambitions for hypertension, high cholesterol and atrial fibrillation. Sharing ideas around CVD Prevent, how DES may improve standards of care for CV patients through SMRs and medicines optimisation, and anticipating the IIF 2021/22 focus on CVD diagnosis and prevention.
This meeting is sponsored by Bristol Myers Squibb Pharmaceuticals.
|Agenda||Download Agenda PDF|
|Contact Name||Laura Carr|
|More Details||Email for more details.|
|Your booking is always provisional until we confirm it!|
|Join Waiting List|